Single-pill treatment proves as effective at suppressing virus as multi-pill therapy, while long-acting preventive injections ...
Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...
A single-pill treatment to suppress HIV proved as effective as existing therapies of up to 11 tablets daily, the latest advance in a scientific “golden age” for treating the virus even as rich ...
– Pivotal Phase 3 Findings Support the Potential of a Novel Single-Tablet Combination of Bictegravir and Lenacapavir for HIV Treatment – – Latest Data from the PURPOSE Program Further Demonstrates the ...
Although HIV infection remains a global public health challenge, ART has transformed it from a fatal illness to a manageable lifetime condition for those who are successfully being treated.Initially, ...
A growing number of states are rolling back financial help for HIV medications, according to a recent analysis.
The Philadelphia HIV Resource Finder allows Philadelphians to search for treatment and prevention resources throughout the city.
Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results